M
Ming Zhou
Researcher at Cleveland Clinic
Publications - 165
Citations - 15633
Ming Zhou is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Prostate cancer & Renal cell carcinoma. The author has an hindex of 57, co-authored 155 publications receiving 14539 citations. Previous affiliations of Ming Zhou include University of Michigan & Case Western Reserve University.
Papers
More filters
Journal ArticleDOI
The polycomb group protein EZH2 is involved in progression of prostate cancer
Sooryanarayana Varambally,Saravana M. Dhanasekaran,Ming Zhou,Terrence R. Barrette,Chandan Kumar-Sinha,Martin G. Sanda,Debashis Ghosh,Kenneth J. Pienta,Richard George Antonius Bernardus Sewalt,Arie P. Otte,Mark A. Rubin,Arul M. Chinnaiyan +11 more
TL;DR: Dysregulated expression of EZH2 may be involved in the progression of prostate cancer, as well as being a marker that distinguishes indolent prostate cancer from those at risk of lethal progression.
Journal ArticleDOI
The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia
John R. Srigley,Brett Delahunt,John N. Eble,Lars Egevad,Jonathan I. Epstein,David J. Grignon,Ondrej Hes,Holger Moch,Rodolfo Montironi,Satish K. Tickoo,Ming Zhou,Pedram Argani,Anila Abraham,Adebowale J. Adeniran,Khalid Ahmed,Hikmat Al Ahmadie,Ferran Algaba,Robert W. Allan,Mahul B. Amin,Ulrika Axcrona,Marc Barry,Dilek Ertoy Baydar,Louis R. Bégin,Daniel M. Berney,Peter Bethwaite,Athanase Billis,Ruth Birbe,Stephen M. Bonsib,David G. Bostwick,Fadi Brimo,Helen P. Cathro,Ying-Bei Chen,Liang Cheng,John C. Cheville,Yong Mee Cho,Ai Ying Chuang,Cynthia Cohen,Henry Crist,Warick Delprado,Fang Ming Deng,Andrew Evans,Oluwole Fadare,Daniel A. Fajardo,Sara M. Falzarano,Samson W. Fine,Stewart Fleming,Eddie Fridman,Bungo Furusato,Masoud Ganji,Masoumeh Ghayouri,Giovanna A. Giannico,Neriman Gokden,David J. Griffiths,Nilesh S. Gupta,Omar Hameed,Michelle S. Hirsch,Jiaoti Huang,Wei Huang,Christina Hulsbergen Van De Kaa,Peter A. Humphrey,Sundus Hussein,Kenneth A. Iczkowski,Rafael E. Jimenez,Edward C. Jones,Laura Irene Jufe,James G. Kench,Masatoshi Kida,Glen Kristiansen,Lakshmi P. Kunju,Zhaoli Lane,Mathieu Latour,Claudio Lewin,Kathrine Lie,Josep Lloreta,Barbara Loftus,Antonio Lopez-Beltran,Fiona Maclean,Cristina Magi-Galluzzi,Guido Martignoni,Teresa McHale,Jesse K. McKenney,Maria Merino,Rose Miller,Hiroshi Miyamoto,Hedwig Murphy,John N. Nacey,Tipu Nazeer,Gabriella Nesi,George J. Netto,Peter W. Nichols,Marie O'Donnell,Semra Olgac,Roberto Orozco,Adeboye O. Osunkoya,Aysim Ozagari,Chin Chen Pan,Anil V. Parwani,Joanna Perry-Keene,Constantina Petraki,Maria M. Picken,Maria Pyda-Karwicka,Victor E. Reuter,Katayoon Rezaei,Nathalie Rioux-Leclercq,Brian D. Robinson,Stephen Rohan,Ruben Ronchetti,Laurie Russell,Hemamali Samaratunga,Marina Scarpelli,Ahmed Shabaik,Rajal B. Shah,Jonathan H Shanks,Steven S. Shen,Maria Shevchuk,Mathilde Sibony,Bhuvana Srinivasan,Martin Susani,Sueli Suzigan,Joan Sweet,Hiroyuki Takahashi,Pheroze Tamboli,Puay Hoon Tan,Isabel Trias,Kiril Trpkov,Larry True,Toyonori Tsuzuki,Funda Vakar-Lopez,Theo H. van der Kwast,Cheng Wang,Anne Y. Warren,Jorge L. Yao,Asli Yilmaz,Jin Zhao,Debra L. Zynger +134 more
TL;DR: The classification working group of the International Society of Urological Pathology consensus conference on renal neoplasia was in charge of making recommendations regarding additions and changes to the current World Health Organization Classification of Renal Tumors, with consensus that 5 entities should be recognized as new distinct epithelial tumors within the classification system.
Journal ArticleDOI
α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer
Mark A. Rubin,Ming Zhou,Saravana M. Dhanasekaran,Sooryanarayana Varambally,Terrence R. Barrette,Martin G. Sanda,Kenneth J. Pienta,Debashis Ghosh,Arul M. Chinnaiyan +8 more
TL;DR: AMACR was shown to be overexpressed in prostate cancer using independent experimental methods and prostate cancer specimens, and may be useful in the interpretation of prostate needle biopsy specimens that are diagnostically challenging.
Journal ArticleDOI
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.
Rajal B. Shah,Rohit Mehra,Arul M. Chinnaiyan,Ronglai Shen,Debashis Ghosh,Ming Zhou,Gary R. MacVicar,Soorynarayana Varambally,Jason Harwood,Tarek A. Bismar,Robert Kim,Mark A. Rubin,Kenneth J. Pienta +12 more
TL;DR: Metastatic hormone-refractory prostate cancer has a heterogeneous morphology, immunophenotype, and genotype, demonstrating that “metastatic disease” is a group of diseases even within the same patient.
Journal ArticleDOI
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
Brett Delahunt,John C. Cheville,Guido Martignoni,Peter A. Humphrey,Cristina Magi-Galluzzi,Jesse K. McKenney,Lars Egevad,Ferran Algaba,Holger Moch,David J. Grignon,Rodolfo Montironi,John R. Srigley,John R. Srigley,Anila Abraham,Adebowale J. Adeniran,Khalid Ahmed,Hikmat Al Ahmadie,Robert W. Allan,Mahul B. Amin,Pedram Argani,Ulrika Axcrona,Marc Barry,Dilek Ertoy Baydar,Louis R. Bégin,Daniel M. Berney,Peter Bethwaite,Athanase Billis,Ruth Birbe,Stephen M. Bonsib,David G. Bostwick,Fadi Brimo,Helen P. Cathro,Ying-Bei Chen,Liang Cheng,Yong Mee Cho,Ai Ying Chuang,Cynthia Cohen,Henry Crist,Warick Delprado,Fang Ming Deng,Jonathan I. Epstein,Andrew Evans,Oluwole Fadare,Daniel A. Fajardo,Sara M. Falzarano,Samson W. Fine,Stewart Fleming,Eddie Fridman,Bungo Furusato,Masoud Ganji,Masoumeh Ghayouri,Giovanna A. Giannico,Neriman Gokden,David J. Griffiths,Nilesh S. Gupta,Omar Hameed,Ondrej Hes,Michelle S. Hirsch,Jiaoti Huang,Wei Huang,Christina Hulsbergen Van De Kaa,Sundus Hussein,Kenneth A. Iczkowski,Rafael E. Jimenez,Edward C. Jones,Laura Irene Jufe,James G. Kench,Masatoshi Kida,Glen Kristiansen,Lakshmi P. Kunju,Zhaoli Lane,Mathieu Latour,Claudio Lewin,Kathrine Lie,Josep Lloreta,Barbara Loftus,Antonio Lopez-Beltran,Fiona Maclean,Teresa McHale,Maria Merino,Rose Miller,Hiroshi Miyamoto,Hedwig Murphy,John N. Nacey,Tipu Nazeer,Gabriella Nesi,George J. Netto,Peter W. Nichols,Marie O'Donnell,Semra Olgac,Roberto Orozco,Adeboye O. Osunkoya,Aysim Ozagari,Chin Chen Pan,Anil V. Parwani,Joanna Perry-Keene,Constantina Petraki,Maria M. Picken,Maria Pyda-Karwicka,Victor E. Reuter,Katayoon Rezaei,Nathalie Rioux-Leclercq,Brian D. Robinson,Stephen Rohan,Ruben Ronchetti,Laurie Russell,Marina Scarpelli,Ahmed Shabaik,Rajal B. Shah,Jonathan H Shanks,Steven S. Shen,Maria Shevchuk,Mathilde Sibony,Bhuvana Srinivasan,Martin Susani,Sueli Suzigan,Joan Sweet,Hiroyuki Takahashi,Puay Hoon Tan,Satish K. Tickoo,Isabel Trias,Larry True,Toyonori Tsuzuki,Funda Vakar-Lopez,Theo H. van der Kwast,Cheng Wang,Anne Y. Warren,Jorge L. Yao,Asli Yilmaz,Jin Zhao,Ming Zhou,Debra L. Zynger +131 more
TL;DR: The International Society of Urological Pathology 2012 Consensus Conference made recommendations regarding classification, prognostic factors, staging, and immunohistochemical and molecular assessment of adult renal tumors.